Uninvolved and lesional skin of untreated and treated patients with atopic eczema has been investigated immunohistochemically to determine the conditions in which IgE bearing CDla+ Langerhans cells/indeterminate cells ( LC IC) occur in this disease. IgE-bearing epidermal dendritic cells were present in patients with elevated IgE serum level (> 300 UI/ml) and the staining pattern was stronger in lesional skin. On double immunostaining, a subpopulation of CDla+ LC IC was found not to bear IgE molecules as determined by the ratio IgE+ CDla+ cells on serial sections as well. The ratio IgE+ CDla+ cells decreased in patients who underwent a local therapy with glucocorticosteroids. These results suggest that the expression of IgE receptors and/or binding of IgE molecules on epidermal LC IC in atopic eczema may be controlled by a complex network of mediators from the epidermis or the inflammatory infiltrate, or both, and that this phenomenon could be down regulated by glucocorticosteroids. © 1989.
CITATION STYLE
Bieber, T., Dannenberg, B., Prinz, J. C., Peter Rieber, E., Stolz, W., Braun-Falco, O., & Ring, J. (1989). Occurrence of IgE-bearing epidermal langerhans cells in atopic eczema: A study of the time course of the lesion’s and with regard to the IgE serum level. Journal of Investigative Dermatology, 93(2), 215–219. https://doi.org/10.1111/1523-1747.ep12277574
Mendeley helps you to discover research relevant for your work.